MRI Scan to Predict Liver Cancer Treatment Response
Part of Cancer, Digestive system clinical trials.
This trial uses a special type of MRI scan to see if doctors can predict how well a liver cancer treatment (called TACE) will work for you. The scan may help doctors understand your treatment response better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cancer (HCC)
- You are scheduled for or have had TACE treatment (a procedure that delivers cancer-fighting drugs directly to the liver)
- You do not have significant lung or breathing disease
- You can lie still in an MRI machine for about 2 hours
- You do not have a pacemaker, metal implants, or other devices that MRI cannot scan
- You are not allergic to MRI contrast dye (the liquid used to make images clearer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of CT scan (spectral CT) to see how well liver cancer has responded to a previous TACE treatment. If you've already had TACE for your liver cancer, this scan may help your doctors decide on the next steps, such as surgery or another procedure.
This trial uses special MRI scans to learn more about liver cancer (hepatocellular carcinoma) before and during treatment with TACE or SIRT. It may help doctors better understand how the tumor responds to therapy.
This study compares a shorter MRI scan to standard imaging for checking if liver cancer has come back after a treatment called TACE. It aims to see if the abbreviated MRI can be just as good but faster and more comfortable for patients.
This trial compares a shorter MRI using a special dye to a CT scan for detecting liver cancer recurrence in people who have been cancer-free for at least two years after surgery or local treatment.
This study tests a new type of MRI that can look at the liver in more detail. It compares images from people with liver cancer and healthy people to see if it can help doctors better understand or detect the disease.
This study looks at ways to improve screening for liver cancer in adults with long-term liver disease. It may help catch liver cancer earlier, which can make treatment easier.
Hear when a new TACE trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.